good value

  1. 143 Posts.
    --cash on hand =2.2c

    --licensing deal with SIOC (Avexa's HIV integrase inhibitor program)=30c (no development cost)

    -initiate an independent review may make apricitabine(ATC) alive =70c

    -all other asset =10c(conservertive estimate)

    2.2+30+70+10=1.122per share

    the share price now only 3 cent now..... great buy
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.